BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14707288)

  • 21. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoter.
    Marcel V; Vijayakumar V; Fernández-Cuesta L; Hafsi H; Sagne C; Hautefeuille A; Olivier M; Hainaut P
    Oncogene; 2010 May; 29(18):2691-700. PubMed ID: 20190805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of apoptotic genes by Rb in human versus mouse cells.
    Young AP; Longmore GD
    Oncogene; 2004 Apr; 23(15):2587-99. PubMed ID: 15048095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts.
    Jackson JG; Pereira-Smith OM
    Cancer Res; 2006 Sep; 66(17):8356-60. PubMed ID: 16951143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
    Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
    Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
    Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines.
    Shaked H; Shiff I; Kott-Gutkowski M; Siegfried Z; Haupt Y; Simon I
    Cancer Res; 2008 Dec; 68(23):9671-7. PubMed ID: 19047144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothermia causes a reversible, p53-mediated cell cycle arrest in cultured fibroblasts.
    Matijasevic Z; Snyder JE; Ludlum DB
    Oncol Res; 1998; 10(11-12):605-10. PubMed ID: 10367942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitofusin-2 is a novel direct target of p53.
    Wang W; Cheng X; Lu J; Wei J; Fu G; Zhu F; Jia C; Zhou L; Xie H; Zheng S
    Biochem Biophys Res Commun; 2010 Oct; 400(4):587-92. PubMed ID: 20804729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of SCN3B as a novel p53-inducible proapoptotic gene.
    Adachi K; Toyota M; Sasaki Y; Yamashita T; Ishida S; Ohe-Toyota M; Maruyama R; Hinoda Y; Saito T; Imai K; Kudo R; Tokino T
    Oncogene; 2004 Oct; 23(47):7791-8. PubMed ID: 15334053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods to study p53-repressed promoters.
    Dumont P; Della Pietra A; Murphy ME
    Methods Mol Biol; 2003; 234():111-20. PubMed ID: 12824528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cellular response to p53: the decision between life and death.
    Sionov RV; Haupt Y
    Oncogene; 1999 Nov; 18(45):6145-57. PubMed ID: 10557106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.
    Qian H; Wang T; Naumovski L; Lopez CD; Brachmann RK
    Oncogene; 2002 Nov; 21(51):7901-11. PubMed ID: 12420228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress.
    Amundson SA; Myers TG; Fornace AJ
    Oncogene; 1998 Dec; 17(25):3287-99. PubMed ID: 9916991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perp is a mediator of p53-dependent apoptosis in diverse cell types.
    Ihrie RA; Reczek E; Horner JS; Khachatrian L; Sage J; Jacks T; Attardi LD
    Curr Biol; 2003 Nov; 13(22):1985-90. PubMed ID: 14614825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic transcriptional activation of the MCK promoter by p53: tetramers link separated DNA response elements by DNA looping.
    Jackson P; Mastrangelo I; Reed M; Tegtmeyer P; Yardley G; Barrett J
    Oncogene; 1998 Jan; 16(2):283-92. PubMed ID: 9464547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The complex interactions of p53 with target DNA: we learn as we go.
    Kim E; Deppert W
    Biochem Cell Biol; 2003 Jun; 81(3):141-50. PubMed ID: 12897847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells.
    Davies L; Spiller D; White MR; Grierson I; Paraoan L
    Cell Death Dis; 2011 Mar; 2(3):e136. PubMed ID: 21451571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERP.
    Roberts O; Paraoan L
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188393. PubMed ID: 32679166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel p53-dependent apoptosis function of TARSH in tumor development.
    Wakoh T; Sugimoto M; Terauchi K; Shimada J; Maruyama M
    Nagoya J Med Sci; 2009 Sep; 71(3-4):109-14. PubMed ID: 19994723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.